These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10746699)

  • 21. Among the best.
    Jayaraman KS
    Nature; 2005 Jul; 436(7050):492-5. PubMed ID: 16049476
    [No Abstract]   [Full Text] [Related]  

  • 22. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 23. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 24. Northern England: rising star.
    Smaglik P
    Nature; 2003 Sep; 425(6956):430-3. PubMed ID: 14508497
    [No Abstract]   [Full Text] [Related]  

  • 25. Canada. Amgen splits with lab, but its money lingers.
    Kondro W
    Science; 2002 Jun; 296(5576):2123-4. PubMed ID: 12077379
    [No Abstract]   [Full Text] [Related]  

  • 26. Foundation's funding.
    Kowalski HE
    Nature; 2002 May; 417(6887):379. PubMed ID: 12024190
    [No Abstract]   [Full Text] [Related]  

  • 27. Biomedical research. Australia pushes stem cell advantage.
    Dayton L
    Science; 2002 Jun; 296(5574):1779-81. PubMed ID: 12052925
    [No Abstract]   [Full Text] [Related]  

  • 28. Cures on the cob.
    Roosevelt M
    Time; 2003 May; 161(21):56-7. PubMed ID: 12800326
    [No Abstract]   [Full Text] [Related]  

  • 29. Possibilities for funding of applied biotechnology research in the sixth Framework Programme.
    Lucas J
    Commun Agric Appl Biol Sci; 2003; 68(2 Pt A):3-12. PubMed ID: 15296131
    [No Abstract]   [Full Text] [Related]  

  • 30. Biotechnology, bioremediation, and blue genes.
    Bialy H
    Nat Biotechnol; 1997 Feb; 15(2):110. PubMed ID: 9035117
    [No Abstract]   [Full Text] [Related]  

  • 31. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 32. Was PolyMASC's early demise self-inflicted?
    Michael A
    Nat Biotechnol; 1999 Jul; 17(7):633. PubMed ID: 10409347
    [No Abstract]   [Full Text] [Related]  

  • 33. Materials exchange deal meager boost to India's biotech.
    Jayaraman KS
    Nat Biotechnol; 2005 Sep; 23(9):1031. PubMed ID: 16151380
    [No Abstract]   [Full Text] [Related]  

  • 34. Inherited wealth.
    Wyke A
    Economist; 1988 Apr; 307():3-18. PubMed ID: 17256228
    [No Abstract]   [Full Text] [Related]  

  • 35. France boosts funding for biotechnology start-ups.
    Goodman S
    Nature; 2001 Dec; 414(6864):573. PubMed ID: 11740520
    [No Abstract]   [Full Text] [Related]  

  • 36. Biotechnology and bioeconomy in China.
    Li Q; Zhao Q; Hu Y; Wang H
    Biotechnol J; 2006 Nov; 1(11):1205-14. PubMed ID: 17109491
    [TBL] [Abstract][Full Text] [Related]  

  • 37. India produces homegrown GM cotton.
    Jayaraman KS
    Nat Biotechnol; 2004 Mar; 22(3):255-6. PubMed ID: 14990937
    [No Abstract]   [Full Text] [Related]  

  • 38. Bush FY 2002 federal budget request vague.
    Fox JL
    Nat Biotechnol; 2001 Apr; 19(4):290. PubMed ID: 11283554
    [No Abstract]   [Full Text] [Related]  

  • 39. Building public-private research partnerships in troubled times.
    Singh S
    Cell; 2009 Mar; 136(6):987-9. PubMed ID: 19303838
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transgenic plant science priorities.
    Pelletier D
    Nat Biotechnol; 2006 May; 24(5):498; author reply 499. PubMed ID: 16680123
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.